Recommendations from the 2nd Consensus Workshop on Analytical Treatment Interruption in HIV Research Trials
Year: 2026
Type: article
Source: The Lancet HIV
Authors: Thumbi Ndung'u, Krista L Dong, Donn J Colby, Steven G Deeks, Mark F Cotton, Karine Dubé, Philip J Goulder, Boris Julg, Moses Nsubuga, Gbolahan Ajibola, Katharine J Bar, Nomonde Bengu, Mutsa Bwakura-Dangarembizi, Marina Caskey, Gabriela Cromhout, Adeodata R Kekitiinwa, William Kilembe, Louise Kuhn, Udom Likhitwonnawut, Nyaradzo M Mgodi, Deborah Persaud, Michael J Peluso, Thomas A Rasmussen, Matthew Romo, Carlo Sacdalan, Wadzanai Samaneka, Roger Shapiro, Ole S Søgaard, Gareth Tudor-Williams, Charity Wambui, Randall Tressler, Sharon R Lewin, Trevor A Crowell, Victoria O Kasprowicz, Lydie Trautmann
Institutions: Africa Health Research Institute, University College London, Mass General Brigham, Massachusetts Institute of Technology, University of KwaZulu-Natal, Harvard University, Ragon Institute of MGH, MIT and Harvard, Massachusetts General Hospital, Henry M. Jackson Foundation, Walter Reed Army Institute of Research, University of California, San Francisco, Stellenbosch University, Tygerberg Hospital, University of California San Diego, University of Oxford, University of Pennsylvania, Umkhuseli Innovation and Research Management, University of Zimbabwe, Rockefeller University, Baylor College of Medicine Children’s Foundation, Columbia University Irving Medical Center, Columbia University, Johns Hopkins University, Johns Hopkins Medicine, Aarhus University, Chulalongkorn University, Imperial College London, Moi University, National Institutes of Health, National Institute of Allergy and Infectious Diseases, The Royal Melbourne Hospital, The University of Melbourne, The Alfred Hospital, Peter Doherty Institute, Monash University
Language: English
Topic: HIV Research and Treatment
Subfield: Virology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W7131064260